Winner page - background image

Winner

ProteoFormiX BV

Best Pathology Biomarker Discovery Technology 2026
GHP Molecular Imaging Innovation Award 2026

Biotechnology & Lifesciences Awards 2026

Award logo for winner - side image

ProteoFormiX BV

Biotechnology & Lifesciences Awards 2026

Best Pathology Biomarker Discovery Technology 2026
GHP Molecular Imaging Innovation Award 2026
ProteoFormiX markets patent protected technology for the high-resolution mass spectrometry imaging of peptides and metabolites from FFPE (formaldehyde-fixed, paraffin-embedded) biobanked material, available in every hospital on the globe. Today this material is only employed by (histo)pathologists for microscopy histological analyses. This technology, called mass spectrometry histochemistry, is currently being rolled out as innovative translational disease biomarker discovery tool.
Visit Website